Potentiated Interaction between Ineffective Doses of Budesonide and Formoterol to Control the Inhaled Cadmium-Induced Up-Regulation of Metalloproteinases and Acute Pulmonary Inflammation in Rats
Authors:
Open Access
- 14 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e109136
Abstract
The anti-inflammatory properties of glucocorticoids are well known but their protective effects exerted with a low potency against heavy metals-induced pulmonary inflammation remain unclear. In this study, a model of acute pulmonary inflammation induced by a single inhalation of cadmium in male Sprague-Dawley rats was used to investigate whether formoterol can improve the anti-inflammatory effects of budesonide. The cadmium-related inflammatory responses, including matrix metalloproteinase-9 (MMP-9) activity, were evaluated. Compared to the values obtained in rats exposed to cadmium, pretreatment of inhaled budesonide (0.5 mg/15 ml) elicited a significant decrease in total cell and neutrophil counts in bronchoalveolar lavage fluid (BALF) associated with a significant reduction of MMP-9 activity which was highly correlated with the number of inflammatory cells in BALF. Additionally, cadmium-induced lung injuries characterized by inflammatory cell infiltration within alveoli and the interstitium were attenuated by the pre-treatment of budesonide. Though the low concentration of budesonide (0.25 mg/15 ml) exerted a very limited inhibitory effects in the present rat model, its combination with an inefficient concentration of formoterol (0.5 mg/30 ml) showed an enhanced inhibitory effect on neutrophil and total cell counts as well as on the histological lung injuries associated with a potentiation of inhibition on the MMP-9 activity. In conclusion, high concentration of budesonide alone could partially protect the lungs against cadmium exposure induced-acute neutrophilic pulmonary inflammation via the inhibition of MMP-9 activity. The combination with formoterol could enhance the protective effects of both drugs, suggesting a new therapeutic strategy for the treatment of heavy metals-induced lung diseases.Keywords
This publication has 44 references indexed in Scilit:
- Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPDPLOS ONE, 2012
- Interaction of matrix metalloproteinases with pulmonary pollutants: Table 1–European Respiratory Journal, 2012
- The Role of Matrix Metalloproteinase-9 in Cigarette Smoke–induced EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPDPulmonary Pharmacology & Therapeutics, 2010
- Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways diseaseRespiratory Research, 2010
- Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approachJournal of Inflammation, 2009
- Early short-termversusprolonged low-dose methylprednisolone therapy in acute lung injuryEuropean Respiratory Journal, 2008
- Steroid-Resistant Neutrophilic Inflammation in a Mouse Model of an Acute Exacerbation of AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smokeJournal of Molecular Medicine, 2008
- Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseasesEuropean Journal of Pharmacology, 2006